The TASP1 overexpression significantly increased the expressions of TASP1 and p-AKT in SGC-7901 cells and BGC-823 cells, and the supplement of AKT/p-AKT inhibitor LY294002 in TASP1-overexpressing GC cells did not change the TASP1 expressions but decreased the expressions of p-AKT (Figures 5(a) and 5(b)). The gene discussed is TASP1; the disease is gastric cancer.